Cargando…

Angiotensin-converting enzyme inhibitor for post-transcatheter aortic valve implantation patients: study protocol for a multicenter randomized, open-label blinded endpoint control trial

BACKGROUND: With the expanded utilization of transcatheter aortic valve implantation (TAVI) to younger and lower surgical risk patients with severe aortic stenosis (AS), optimal medical therapy after TAVI procedure has become the main concern. Renin-angiotensin system inhibitors (RASi) are widely ut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Yan Biao, Xia, Congying, Cheng, Yiheng, Li, Qiao, Wei, Xin, Ou, Yuanweixiang, Chen, Fei, Li, Yijian, Liu, Qi, Xiong, Tianyuan, Zhao, Zhengang, Peng, Yong, Wei, Jiafu, Feng, Yuan, Chen, Mao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286566/ https://www.ncbi.nlm.nih.gov/pubmed/34275476 http://dx.doi.org/10.1186/s13063-021-05411-5

Ejemplares similares

Incidence, Predictors, and Outcome of Paravalvular Leak after Transcatheter Aortic Valve Implantation
por: Hagar, Abdullah, et al.
Publicado: (2020)

Metabolic Modulation and Potential Biomarkers of the Prognosis Identification for Severe Aortic Stenosis after TAVR by a Metabolomics Study
por: Liao, Yanbiao, et al.
Publicado: (2020)

Gender differences in mortality following tanscatheter aortic valve replacement (TAVR): a single-centre retrospective analysis from China
por: Liu, Qi, et al.
Publicado: (2023)

Deep Learning in Prediction of Late Major Bleeding After Transcatheter Aortic Valve Replacement
por: Jia, Yuheng, et al.
Publicado: (2022)

Differences in metabolic profiles between bicuspid and tricuspid aortic stenosis in the setting of transcatheter aortic valve replacement
por: Xiong, Tian-Yuan, et al.
Publicado: (2020)

Patients With Bicuspid Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis
por: Zhang, Yi, et al.
Publicado: (2022)

Transcatheter Mitral Valve-in-Valve Implantation With a New Transcatheter Heart Valve for Bioprosthetic Degeneration
por: Lu, Yuntao, et al.
Publicado: (2022)

The incidence and predictors of high-degree atrioventricular block in patients with bicuspid aortic valve receiving self-expandable transcatheter aortic valve implantation
por: OU, Yuan-Weixiang, et al.
Publicado: (2021)

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium(†)
por: Leon, Martin B., et al.
Publicado: (2011)

Effects of the angiotensin-converting enzyme inhibitor alacepril in dogs with mitral valve disease
por: HORI, Yasutomo, et al.
Publicado: (2018)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction
por: Chen, Chih-Wei, et al.
Publicado: (2023)

Angiotensin-converting enzymes modulate aphid–plant interactions
por: Wang, Wei, et al.
Publicado: (2015)

“Cusp-overlap” technique simplifies the implantation of Chinese domestic transcatheter valve in transcatheter aortic valve implantation
por: Chen, Mi, et al.
Publicado: (2021)

Hemodynamics of transcatheter tricuspid valve replacement with Lux-Valve
por: Wei, Wang, et al.
Publicado: (2022)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang, Chao, et al.
Publicado: (2021)

Transcatheter Aortic Valve Replacement in Patients with Aortic Stenosis Having Coronary Cusp Fusion versus Mixed Cusp Fusion Nonraphe Bicuspid Aortic Valve
por: Lei, Wen-hua, et al.
Publicado: (2019)

Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study
por: Hakeam, Hakeam A., et al.
Publicado: (2020)

Effects of Transapical Transcatheter Mitral Valve Implantation
por: Hsiung, Ming-Chon, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study
por: Butler-Laporte, Guillaume, et al.
Publicado: (2020)

Posterior urethral valves: Persistent renin angiotensin system activation after valve ablation and role of pre-emptive therapy with angiotensin converting enzyme-inhibitors on renal recovery
por: Bajpai, Minu, et al.
Publicado: (2013)

Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers and hemorrhoids: A nationwide, population-based study
por: Hu, Wei-Syun, et al.
Publicado: (2023)

Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
por: Li, Xiao-Long, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Midterm Degeneration of Transcatheter Heart Valve Device following Valve-in-Valve Transcatheter Aortic Valve Replacement Requiring Repeat Transcatheter Aortic Valve Replacement
por: Duncan, Alison, et al.
Publicado: (2020)

Impact of Mean Platelet Volume on Combined Safety Endpoint and Vascular and Bleeding Complications following Percutaneous Transfemoral Transcatheter Aortic Valve Implantation
por: Magri, Caroline J., et al.
Publicado: (2013)

Clinical significance and molecular mechanism of angiotensin-converting enzyme 2 in hepatocellular carcinoma tissues
por: Huang, Wei-Jian, et al.
Publicado: (2021)

Discovery and biosynthesis of karnamicins as angiotensin converting enzyme inhibitors
por: Yu, Zhiyin, et al.
Publicado: (2023)

The Predictors of Conduction Disturbances Following Transcatheter Aortic Valve Replacement in Patients With Bicuspid Aortic Valve: A Multicenter Study
por: Guo, Yuchao, et al.
Publicado: (2021)

Transcatheter Aortic Valve Replacement Valve in Transcatheter Aortic Valve Replacement Valve for Severe Periprosthetic Regurgitation
por: Nandy, Sneha, et al.
Publicado: (2020)

Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era
por: Testa, Luca, et al.
Publicado: (2019)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_48ukjht6v7g0obqbcs4gir0u4j